Blood Pressure Meds and Supplements: What to Avoid

Which way potassium moves depends on the blood pressure drug. Hydrochlorothiazide is not potassium sparing: it increases potassium loss, and 7% to 56% of people on thiazide diuretics develop low potassium¹. Lisinopril, losartan and other ACE inhibitors and ARBs do the opposite, and up to 10% of patients develop at least mild high potassium².

So the same potassium pill can help one person and harm another. Check which class you take before you add potassium, a potassium-based salt substitute or any other mineral. Our potassium page and elevated blood pressure page cover the evidence for the minerals themselves; this guide covers how they interact with the drugs.

Yes. The prescribing label states that the increase in sodium excretion "may be accompanied by some loss of potassium and bicarbonate". It gives a usual adult starting dose of 25 mg a day and says doses above 50 mg a day are often associated with marked reductions in serum potassium³. A 2022 review put the prevalence of low potassium (hypokalemia) at 7% to 56% of thiazide users. Risk is higher in women and in Black patients¹.

Is hydrochlorothiazide potassium sparing?

No. Potassium-sparing diuretics such as amiloride and spironolactone reduce potassium loss. Thiazides such as hydrochlorothiazide, and loop diuretics, increase it and can cause hypokalemia⁴. Some tablets pair hydrochlorothiazide with a potassium-sparing drug, an ACE inhibitor or an ARB, and these combinations reduce the risk of hypokalemia¹. They also change the potassium advice in the next section, so check what your tablet contains.

What are the signs of a potassium imbalance?

Symptoms can be absent, and when they appear they are non-specific: diuretic-induced low potassium ranges from no symptoms to fatal arrhythmia, so diagnosis rests on a blood test, and an ECG helps identify severe cases¹. Mild low potassium can cause constipation, fatigue, muscle weakness and malaise. High potassium can also be silent, but severe cases cause muscle weakness, paralysis, palpitations, prickling in the hands and feet, and dangerous heart rhythms⁴.

The hydrochlorothiazide label lists warning signs of an electrolyte imbalance: dry mouth, thirst, weakness, drowsiness, confusion, muscle pains or cramps, low blood pressure, a fast heartbeat and nausea. It adds that low potassium can sensitize the heart to the toxic effects of digitalis³. High potassium on an ACE inhibitor or ARB can also cause dangerous arrhythmias². If you take either drug type, ask when your next potassium test is due, and call your doctor if these signs appear.

Only if a blood test shows low potassium and your prescriber agrees. First check whether your tablet is hydrochlorothiazide alone. The label for the triamterene and hydrochlorothiazide combination says potassium supplements, potassium-containing salt substitutes and potassium-enriched diets should not be used with it, and warns that uncorrected high potassium may be fatal⁵. Amiloride and spironolactone, the other potassium-sparing partners, can also cause hyperkalemia⁴. If your tablet also contains lisinopril or losartan, that drug reduces the potassium loss¹, and the cautions in the next section apply.

For hydrochlorothiazide alone, one trial shows what works. Of 447 hypertensive patients, 252 developed hypokalemia on hydrochlorothiazide 50 mg a day. They were randomized to extra potassium at 20 mmol a day, extra potassium at 40 mmol a day, or a hydrochlorothiazide-triamterene tablet. Potassium rose within 1 week in every group, the 40 mmol dose and the triamterene tablet worked better than 20 mmol, and blood pressure stayed controlled⁶.

Those trial doses are prescription amounts. Most over-the-counter potassium supplements contain no more than 99 mg per serving, because the FDA has ruled that some oral potassium chloride products above that amount are unsafe and others need a warning label⁴. A shelf supplement therefore will not correct a real deficit. If you take hydrochlorothiazide alone, food will help more, and the label itself suggests high-potassium foods as a way to avoid or treat hypokalemia³. Our potassium-rich foods guide lists amounts per serving, and the potassium for blood pressure page covers the trial evidence.

More is not better. A dose-response meta-analysis of 32 trials found a U-shaped curve: the blood pressure benefit weakened above about 30 mmol a day of extra potassium excretion, and pressure rose above about 80 mmol a day. The rise appeared in people on antihypertensive drugs but not in untreated people, though the authors caution that few trials tested intakes that high⁷.

They can. ACE inhibitors such as lisinopril and ARBs such as losartan reduce urinary potassium excretion, which can lead to hyperkalemia⁴. The word potassium in losartan potassium names the salt form of the drug: a 50 mg tablet contains 4.24 mg of potassium⁸, so it is not a supplement, and losartan with hydrochlorothiazide is a different tablet. A review estimated that up to 10% of patients on these drugs develop at least mild hyperkalemia, particularly people with chronic kidney disease. It advised checking baseline potassium and kidney function, and asking about potassium from diet, supplements and other drugs².

The lisinopril label lists the risk factors: renal insufficiency, diabetes, and the concomitant use of potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes. It tells patients not to use potassium salt substitutes without consulting their physician⁹. A 2022 review adds trimethoprim, calcineurin inhibitors, heparins and NSAIDs to the list of interacting drugs¹⁰.

The size of the effect in kidney disease is clear from one trial. In 191 adults with stage G3b-4 chronic kidney disease, 83% of them on renin-angiotensin inhibitors, 40 mmol a day of potassium chloride for 2 weeks raised plasma potassium from 4.3 to 4.7 mmol/L. Hyperkalemia developed in 21 people (11%), and they were older and started with higher potassium. Blood pressure did not change¹¹.

In people whose kidneys clear potassium poorly, because of chronic kidney disease or drugs such as ACE inhibitors or potassium-sparing diuretics, even dietary potassium below the adequate intake can cause hyperkalemia. Type 1 diabetes and heart failure raise the risk too⁴. People with kidney disease should read our chronic kidney disease page before supplementing.

Not automatically. A Cochrane review of 26 trials and 34,961 adults found that low-sodium salt substitutes lowered systolic pressure by 4.76 mm Hg and diastolic pressure by 2.43 mm Hg, and raised blood potassium by 0.12 mmol/L¹². Hyperkalemia rates showed little to no difference from regular salt, but all 26 trials excluded people for whom extra potassium is known to be harmful, so the result does not cover people on ACE inhibitors with kidney disease¹².

The practical rule follows the lisinopril label: ask before using a potassium-based substitute if you take an ACE inhibitor, an ARB or a potassium-sparing diuretic⁹.

Thiazides lower magnesium rather than raise it. Chronic treatment with thiazide and loop diuretics can increase urinary magnesium loss and lead to magnesium depletion, while potassium-sparing diuretics reduce magnesium excretion¹³. The hydrochlorothiazide label says the same: thiazides increase urinary magnesium excretion, which may result in hypomagnesemia³. A 2024 review lists thiazide diuretics among the common causes of hypomagnesemia, defined as serum magnesium below 0.7 mmol/L¹⁴.

Magnesium itself also lowers pressure a little. A meta-analysis of 34 placebo-controlled trials in 2,028 adults found that a median 368 mg a day for 3 months reduced systolic pressure by 2.00 mm Hg and diastolic pressure by 1.78 mm Hg¹⁵. The supplemental upper limit for adults is 350 mg a day¹³. See our magnesium page and magnesium for blood pressure regulation for the evidence, and the magnesium-rich foods guide for diet sources.

Kidney disease changes the picture. The risk of magnesium toxicity rises with impaired kidney function, because the kidneys cannot remove the excess, and toxicity can cause low blood pressure, nausea, muscle weakness, an irregular heartbeat and, at the extreme, cardiac arrest¹³. Potassium-sparing diuretics also reduce magnesium excretion¹³. If you have kidney disease, do not start a magnesium supplement without your doctor's approval.

We found no controlled data on spacing magnesium from ACE inhibitors, ARBs or calcium channel blockers, and the NIH fact sheet's separation advice (2 hours around bisphosphonates, and a longer gap for some antibiotics) does not name those drugs¹³. Ask your pharmacist if you want a schedule for your own combination.

Thiazides and vitamin D both push blood calcium up, so together they can raise it too far. Thiazides reduce urinary calcium excretion and may cause a slight rise in serum calcium³. A drug-related hypercalcemia review explains that thiazides increase calcium reabsorption in the kidney, while vitamin D supplements increase gut absorption and bone resorption¹⁶. The NIH vitamin D fact sheet warns that the combination might lead to hypercalcemia, especially in older adults and in people with reduced kidney function or hyperparathyroidism¹⁷.

At the extreme, the combination can cause calcium-alkali thiazide syndrome. In one case report, a 57-year-old woman, three weeks after parathyroid surgery, was taking calcium carbonate 1 g three times daily, calcitriol, vitamin D3 10,000 units daily, chlorthalidone 25 mg and irbesartan. She arrived with a calcium of 23 mg/dL, confusion and acute kidney injury, and her calcium and creatinine normalized after fluids and furosemide¹⁸. It is one case, after parathyroid surgery, so it shows the mechanism, not how often this happens.

The practical point is to keep calcium and vitamin D supplements to the doses your clinician set. The calcium upper limit counts food, drinks and supplements together: 2,500 mg a day from 19 to 50 years and 2,000 mg from 51^{19, 20}. For vitamin D, the adult upper limit is 4,000 IU (100 mcg) a day¹⁷. Our calcium page and calcium-rich foods guide cover sources and dosing.

Beyond the minerals above, the label names several risks:

• Lithium: diuretics reduce lithium clearance and add a high risk of lithium toxicity³.
• NSAIDs: they can reduce the diuretic and blood pressure effects of thiazides³. With ACE inhibitors they can also worsen kidney function in elderly or volume-depleted patients⁹.
• Sun exposure: hydrochlorothiazide raises non-melanoma skin cancer risk, by about 1 extra squamous cell case per 16,000 patients per year overall and 1 per 6,700 in white patients on a cumulative dose of 50,000 mg or more³.
• Sudden eye pain or blurred vision: acute myopia and angle-closure glaucoma can appear within hours to weeks of starting, and call for stopping the drug under medical advice³.

The skin cancer warning is the "new warning" people search for: the FDA added it to the label in August 2020, after a study in its Sentinel System²¹. The extra risk it describes is small, as the numbers above show.

Three have real evidence behind them.

• Licorice: a meta-analysis of 18 studies in 337 people found that at least 100 mg a day of glycyrrhizic acid raised systolic pressure by 5.45 mm Hg and diastolic by 3.19 mm Hg, and lowered plasma potassium by 0.33 mmol/L²². That adds to thiazide potassium loss and works against the drug.
• Grapefruit juice: it inhibits intestinal CYP3A4, so some calcium channel blockers are absorbed more. The effect is largest with felodipine²³.
• St. John's wort: a review lists clinically significant interactions with verapamil and nifedipine. The main mechanism is induction of CYP3A4 and P-glycoprotein²⁴.

If you take a calcium channel blocker, ask whether your own drug is affected by grapefruit. The review does not rank every drug in the class²³.

Melatonin has one controlled study that matters here. In a double-blind crossover trial, 47 people whose blood pressure was controlled on nifedipine, a calcium channel blocker, took 5 mg of melatonin or a placebo late in the evening for 4 weeks each. On melatonin, 24-hour blood pressure was 6.5/4.9 mm Hg higher and heart rate 3.9 beats a minute higher, and the authors advised caution with unsupervised melatonin in people with high blood pressure²⁵.

Beta blockers are a different case: in a small placebo-controlled trial in 16 people taking atenolol or metoprolol, 2.5 mg of melatonin a night for 3 weeks added 36 minutes of sleep compared with placebo²⁶. If you take a calcium channel blocker and start melatonin, check your home readings.

For potassium with amlodipine, our PubMed search found no controlled interaction studies. Absence of data is not proof of safety, but it means we cannot give a spacing rule.

Supplements that lower blood pressure themselves, such as nattokinase and magnesium, can add to a prescribed drug. Home readings and a clinician's follow-up are the safeguard if you start one. For antidepressant and sleep combinations, see our SSRIs and supplements guide and the melatonin page.

1. Name your drug class. A thiazide such as hydrochlorothiazide pushes potassium down. An ACE inhibitor or ARB pushes it up⁴. Check combination tablets too: with triamterene and hydrochlorothiazide, the label rules out potassium supplements, potassium salt substitutes and potassium-enriched diets⁵.
2. Ask for a blood test before changing minerals. Electrolytes, including potassium and magnesium^{3, 5}, and kidney function if you take an ACE inhibitor or ARB².
3. Raise potassium only when your drug and blood test call for it. On a thiazide alone with low potassium, food beats over-the-counter pills, which rarely exceed 99 mg. On an ACE inhibitor, an ARB or a potassium-sparing diuretic, or with kidney disease, ask before adding potassium from any source, food included⁴.
4. Skip licorice products and check grapefruit. Both are food-level exposures with documented effects^{22, 23}.
5. Keep calcium and vitamin D within the dose you were told. Thiazides change how the body handles calcium³.
6. Tell your pharmacist about every supplement. Lithium and NSAIDs are the other interaction groups on the label³.

Supplements in this guide

• Potassium
• Magnesium
• Calcium
• St. Johns Wort

We searched PubMed through fetch_sources and the Firecrawl research tools for reviews, trials and case reports on diuretics, ACE inhibitors, ARBs, calcium channel blockers, potassium, magnesium, calcium, licorice, grapefruit, St. John's wort and melatonin. We read 16 journal records; the NIH Office of Dietary Supplements fact sheets for potassium, magnesium, calcium and vitamin D; the FDA labels for hydrochlorothiazide, triamterene with hydrochlorothiazide, lisinopril and losartan; and the FDA's 2020 notice on hydrochlorothiazide and skin cancer, all on 14 October 2026. We prioritized meta-analyses, randomized trials and labels. The evidence here is limited: several interactions rest on reviews or a single case report, the melatonin findings come from two small trials, and we did not assess every drug in each class. After an independent review on 14 October 2026 we added the combination-tablet, kidney disease, vitamin D and melatonin cautions. This is general information, not medical advice.

1. Lin Z, et al. Diuretic-induced hypokalaemia: an updated review. Postgrad Med J. 2022;98(1160):477-482. doi:10.1136/postgradmedj-2020-139701
2. Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012;30(3):e156-66. doi:10.1111/j.1755-5922.2010.00258.x
3. U.S. National Library of Medicine, DailyMed. Hydrochlorothiazide tablets: prescribing information. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71691ccf-0ed9-4a14-8da6-7ab9b9698f52
4. National Institutes of Health, Office of Dietary Supplements. Potassium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/
5. U.S. National Library of Medicine, DailyMed. Triamterene and hydrochlorothiazide tablets: prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abf2fe45-8b69-4d3c-981e-289c0aa3e98b
6. Schnaper HW, et al. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide. Arch Intern Med. 1989;149(12):2677-81. https://pubmed.ncbi.nlm.nih.gov/2596940/
7. Filippini T, et al. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2020;9(12):e015719. doi:10.1161/JAHA.119.015719 Our study summary.
8. U.S. National Library of Medicine, DailyMed. Cozaar (losartan potassium) tablets: prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9949448f-c3b9-44ee-94ed-c1aca8c90f39
9. U.S. National Library of Medicine, DailyMed. Lisinopril tablets: prescribing information. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8c50753c-f31b-486c-854c-4eaf6ac11119
10. Mohamed Pakkir Maideen N, et al. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers. Curr Cardiol Rev. 2022;18(6):e110522204611. doi:10.2174/1573403X18666220511152330
11. Gritter M, et al. Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD. J Am Soc Nephrol. 2022;33(9):1779-1789. doi:10.1681/ASN.2022020147
12. Brand A, et al. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women. Cochrane Database Syst Rev. 2022;8(8):CD015207. doi:10.1002/14651858.CD015207
13. National Institutes of Health, Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
14. Kröse JL, et al. Magnesium biology. Nephrol Dial Transplant. 2024;39(12):1965-1975. doi:10.1093/ndt/gfae134
15. Zhang X, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 2016;68(2):324-33. doi:10.1161/HYPERTENSIONAHA.116.07664 Our study summary.
16. Lecoq AL, et al. Drug-Related Hypercalcemia. Endocrinol Metab Clin North Am. 2021;50(4):743-752. doi:10.1016/j.ecl.2021.08.001
17. National Institutes of Health, Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
18. Rehan MA, et al. Calcium Alkali Thiazide Syndrome: What We Need to Know. Cureus. 2020;12(10):e10856. doi:10.7759/cureus.10856
19. National Institutes of Health, Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
20. National Institutes of Health, Office of Dietary Supplements. Calcium: Fact Sheet for Consumers. https://ods.od.nih.gov/factsheets/Calcium-Consumer/
21. U.S. Food and Drug Administration, Sentinel Initiative. FDA Labeling Change: Hydrochlorothiazide and Non-Melanoma Skin Cancer. 20 August 2020. https://www.sentinelinitiative.org/news-events/fda-safety-communications-labeling-changes/fda-labeling-change-hydrochlorothiazide-and
22. Penninkilampi R, et al. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017;31(11):699-707. doi:10.1038/jhh.2017.45
23. Sica DA. Interaction of grapefruit juice and calcium channel blockers. Am J Hypertens. 2006;19(7):768-73. doi:10.1016/j.amjhyper.2005.11.003
24. Di YM, et al. Clinical drugs that interact with St. John's wort and implication in drug development. Curr Pharm Des. 2008;14(17):1723-42. doi:10.2174/138161208784746798
25. Lusardi P, et al. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol. 2000;49(5):423-7. doi:10.1046/j.1365-2125.2000.00195.x
26. Scheer FA, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395-402. doi:10.5665/sleep.2122